Insulet Stock Performance
| PODD Stock | USD 303.15 1.36 0.45% |
On a scale of 0 to 100, Insulet holds a performance score of 4. The company retains a Market Volatility (i.e., Beta) of -0.23, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Insulet are expected to decrease at a much lower rate. During the bear market, Insulet is likely to outperform the market. Please check Insulet's skewness, day typical price, and the relationship between the downside variance and daily balance of power , to make a quick decision on whether Insulet's current trending patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Insulet are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Insulet exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 704.2 M |
Insulet Relative Risk vs. Return Landscape
If you would invest 27,404 in Insulet on March 23, 2025 and sell it today you would earn a total of 2,911 from holding Insulet or generate 10.62% return on investment over 90 days. Insulet is currently generating 0.2169% in daily expected returns and assumes 3.4385% risk (volatility on return distribution) over the 90 days horizon. In different words, 30% of stocks are less volatile than Insulet, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Insulet Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Insulet's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Insulet, and traders can use it to determine the average amount a Insulet's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0631
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PODD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.44 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Insulet is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Insulet by adding it to a well-diversified portfolio.
Insulet Fundamentals Growth
Insulet Stock prices reflect investors' perceptions of the future prospects and financial health of Insulet, and Insulet fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Insulet Stock performance.
| Return On Equity | 0.38 | ||||
| Return On Asset | 0.0694 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 21.65 B | ||||
| Shares Outstanding | 70.37 M | ||||
| Price To Book | 15.96 X | ||||
| Price To Sales | 9.66 X | ||||
| Revenue | 2.07 B | ||||
| EBITDA | 423.7 M | ||||
| Cash And Equivalents | 708.6 M | ||||
| Cash Per Share | 10.21 X | ||||
| Total Debt | 1.39 B | ||||
| Debt To Equity | 3.34 % | ||||
| Book Value Per Share | 18.91 X | ||||
| Cash Flow From Operations | 430.3 M | ||||
| Earnings Per Share | 5.55 X | ||||
| Total Asset | 3.09 B | ||||
| Retained Earnings | 40.3 M | ||||
| Current Asset | 190.76 M | ||||
| Current Liabilities | 65.16 M | ||||
About Insulet Performance
By analyzing Insulet's fundamental ratios, stakeholders can gain valuable insights into Insulet's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Insulet has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Insulet has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. Insulet Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2300 people.Things to note about Insulet performance evaluation
Checking the ongoing alerts about Insulet for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Insulet help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Insulet had very high historical volatility over the last 90 days | |
| Over 100.0% of the company shares are owned by institutional investors |
- Analyzing Insulet's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Insulet's stock is overvalued or undervalued compared to its peers.
- Examining Insulet's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Insulet's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Insulet's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Insulet's stock. These opinions can provide insight into Insulet's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Insulet Stock analysis
When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |